These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31933937)

  • 1. DLC-3 suppresses cellular proliferation, migration, and invasion in triple-negative breast cancer by the Wnt/β-catenin pathway.
    Kong B; Lv ZD; Xia J; Jin LY; Yang ZC
    Int J Clin Exp Pathol; 2019; 12(4):1224-1232. PubMed ID: 31933937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Britannin inhibits hepatocellular carcinoma development and metastasis through the GSK-3β/β-catenin signaling pathway.
    Lu Q; Zhu J; Teng L; Chen C; Bi L; Chen W
    Phytomedicine; 2024 Dec; 135():156126. PubMed ID: 39427522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclovirobuxine D inhibits triple-negative breast cancer via YAP/TAZ suppression and activation of the FOXO3a/PINK1-Parkin pathway-induced mitophagy.
    Wang ZQ; Wu ZX; Chen JW; Li HF; Wu HD; Bao JX; Cheng Y; Dai YW; Wang OC; Dai XX
    Phytomedicine; 2024 Nov; 136():156287. PubMed ID: 39615216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Harmaline in Inhibiting c-Myc, Altering Molecular Typing, and Promoting Apoptosis in Triple-Negative Breast Cancer.
    Xu H; Ma Y; Li H; Song X; Liu Y; Mierzhakenmu Z; Yan K; Xu R; Zhao Z; Yuan H; Dong C
    Breast Cancer (Dove Med Press); 2024; 16():855-866. PubMed ID: 39655230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast Growth Factor Receptor 4 Promotes Triple-Negative Breast Cancer Progression via Regulating Fatty Acid Metabolism Through the AKT/RYR2 Signaling.
    Ye J; Wu S; Quan Q; Ye F; Zhang J; Song C; Fan Y; Cao H; Tang H; Zhao J
    Cancer Med; 2024 Dec; 13(23):e70439. PubMed ID: 39658878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p.
    Yi J; Ye Z; Xu H; Zhang H; Cao H; Li X; Wang T; Dong C; Du Y; Dong S; Zhou W
    Phytomedicine; 2024 Dec; 135():156137. PubMed ID: 39566403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZEB2 reduction contributes to pre-eclampsia via Wnt/β-Catenin pathway.
    Zhang Y; Gu F; Liu Y; Sun Y; Zhang L; Lu D
    Cell Div; 2024 Nov; 19(1):34. PubMed ID: 39614362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gremlin-2 is a novel tumor suppressor that negatively regulates ID1 in breast cancer.
    Jung J; Kim NH; Park J; Lim D; Kwon M; Gil W; Jung S; Go M; Kim C; Cheong YH; Lee MH; Park HS; Eom YB; Park SA
    Breast Cancer Res; 2024 Nov; 26(1):174. PubMed ID: 39614338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The miR-1269a/PCDHGA9/CXCR4/β-catenin pathway promotes colorectal cancer invasion and metastasis.
    Mei H; Luo Q; Weng J; Hao J; Cai J; Zhou R; Bian C; Ye Y; Luo S; Wen Y
    Cell Mol Biol Lett; 2024 Nov; 29(1):144. PubMed ID: 39587482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting Enzyme 2 Suppresses Pulmonary Fibrosis Associated with Wnt and TGF-β1 Signaling Pathways.
    Tang Y; Liu J; Liu L
    Discov Med; 2024 Nov; 36(190):2274-2286. PubMed ID: 39600282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Anti-Tumor Effects of Newcastle Disease Virus and Doxorubicin: Evidence from A Murine Breast Cancer Model.
    Sabri H; Barough MS; Zafari E; Pakjoo M; Mahdavi M; Esmaeili F; Sadeghi S; Sarrami-Forooshani R
    Int Immunopharmacol; 2024 Dec; 143(Pt 2):113481. PubMed ID: 39467343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the role of androgen receptor and androgen receptor variant 7 in TNBC patients and the effect of their targeting by Enzalutamide and EPI-001 in MDA-MB-231.
    Ali BM; El-Abhar HS; Mohamed G; Nassar HR; Aliedin N; Sharaky M; Shouman SA; Kamel M
    J Steroid Biochem Mol Biol; 2025 Jan; 245():106636. PubMed ID: 39536950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Interactions of the Plant Steroid Hormone Epibrassinolide on Human Drug-Sensitive and Drug-Resistant Small-Cell Lung Carcinoma Cells.
    Sadava D; Chen S
    Cancers (Basel); 2024 Nov; 16(22):. PubMed ID: 39594767
    [No Abstract]   [Full Text] [Related]  

  • 14. [GINS1 Enhances Glycolysis, Proliferation and Metastasis in Lung Adenocarcinoma Cells by Activating the Notch/PI3K/AKT/mTORC1 Signaling Pathway].
    Huo Y; Xu X; Ma X; Feng Y
    Zhongguo Fei Ai Za Zhi; 2024 Oct; 27(10):735-744. PubMed ID: 39631830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA SNHG1 Regulates the Wnt/β-Catenin and PI3K/AKT/mTOR Signaling Pathways
    Chen J; Wang F; Xu H; Xu L; Chen D; Wang J; Huang S; Wen Y; Fang L
    Front Oncol; 2020; 10():552907. PubMed ID: 33194612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteolin alleviates airway remodeling in asthma by inhibiting the epithelial-mesenchymal transition via β-catenin regulation.
    Quan J; Xie D; Li Z; Yu X; Liang Z; Chen Y; Wu L; Huang D; Lin L; Fan L
    Phytomedicine; 2024 Dec; 135():156090. PubMed ID: 39393303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
    Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
    Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1 and FOXM1 siRNA co-loaded nanoparticles by disulfide crosslinked PEG-PDMAEMA for the treatment of triple-negative breast cancer and its bone metastases in vitro.
    Wang X; Huang H; Xu W; Gong Y; Shi S; Wan X; Li P
    Drug Dev Ind Pharm; 2024 Sep; 50(9):777-788. PubMed ID: 39286903
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.